Navigation Links
Amilpar - Relevant Fact - Public Offer
Date:12/9/2009

RIO DE JANEIRO, Dec. 9 /PRNewswire-FirstCall/ -- Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managed care organization in Brazil, in addition to the Relevant Facts released on November 19, 2009 and December 2, 2009, informs its shareholders and the market that the initiatives to proceed with the Public Offer defined below were started today, having as Applicant its subsidiary AMIL ASSISTENCIA MEDICA INTERNACIONAL LTDA. The filing to register the public offer for the acquisition of shares issued by Medial Saude S.A. ("Medial") due to the control change, at the price of R$ 17.2066 per share, along with the exit from Novo Mercado and delisting of the company was done at CVM - Comissao de Valores Mobiliarios (Brazilian Securities and Exchange Commission), according to article 254-A of Law 6,404/76, CVM Instruction 361/02, BM&FBovespa's Novo Mercado Regulation and the Bylaws of Medial Saude S.A. ("Public Offer").

Amilpar informs that Medial's economic value per share is subject to confirmation through the valuation report to be prepared according to BM&FBovespa's Novo Mercado rules.

Amilpar will keep the market and its shareholders informed about the conclusion of the above-mentioned offer.

    To access the Relevant Fact, visit our website at www.amilpar.com.br/ir

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155
    invest@amil.com.br
    www.amilpar.com.br/ir

SOURCE Amilpar


'/>"/>
SOURCE Amilpar
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
2. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
3. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
4. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
5. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
6. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
7. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
8. Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks Are You Relevant?
9. Relevant Security and bitRail Debut RevSecure Product Line
10. 30th Anniversary Edition of Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever
11. www.greatplacesinc.com Isthe Leading Internet Resourcefor Current, Relevant, Reliable Advice,Counseling the 76 MillionBaby Boomers Who Are Increasingly Responsible for Their Aging Parents' Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: